DavidPatrickSparlingMDPhD
Pediatric Endocrinology • Oklahoma City, OKPediatric Diabetes Endocrinology
Section Chief
Dr. Sparling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1200 Children's Avenue, Ste 4D
Suite 4D
Oklahoma City, OK 73104Phone+1 405-271-3303
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Endocrinology, 2011 - 2015- New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 2009 - 2011
University of Oklahoma College of MedicineClass of 2009
Certifications & Licensure
OK State Medical License 2015 - 2025
NY State Medical License 2011 - 2017- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Publications & Presentations
PubMed
- 108 citationsContinuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study.Viral N. Shah, Stephanie N. DuBose, Zoey Li, Roy W. Beck, Anne L. Peters
The Journal of Clinical Endocrinology and Metabolism. 2019-10-01 - 49 citationsmTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2Kyeong Jin Kim, Li Qiang, Matthew S. Hayden, David P. Sparling, Nicole H. Purcell
Nature Communications. 2016-01-08 - 17 citationsAdipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity.David P. Sparling, Junjie Yu, Kyeong Jin Kim, Changyu Zhu, Sebastian Brachs
Molecular Metabolism. 2016-02-01
Authored Content
- Real-time continuous glucose monitoring reduced costly diabetes-related events in adolescents and young adults despite lack of short-term reduction in hemoglobin A1cApril 2023
Press Mentions
- New Diabetes Treatment Could Change the Future of the DiseaseMarch 30th, 2024
- 'First Big Step Towards a Cure': Revolutionary Type 1 Diabetes Drug at OU HealthApril 11th, 2024
Professional Memberships
- Member
- Pediatric Endocrine SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
